MTL Projects and Mark Thompson Lifesciences
Summary
Normec Group, a Netherlands-based leader in testing, inspection, certification, and compliance, has successfully acquired MTL Projects and Mark Thompson Lifesciences. These County Durham-based companies specialise in providing consultancy and engineering services to the pharmaceutical, biotech, and medical device industries.
Summary of transaction details:
- Value: Not disclosed
- Sector: Healthcare & Biotech
- Advisor: KBS Corporate (represented by Tom Eatough)
- Key Entities: MTL Projects and Mark Thompson Lifesciences (Target), Normec Group (Acquirer)
- Location: County Durham, UK (Target)
Note: This acquisition is expected to provide MTL Projects and Mark Thompson Lifesciences with a significant catalyst for growth and development, integrating their specialised services into Normec’s expansive Healthcare division and enhancing overall market reach and capabilities within the medical safety and compliance sector.
Related Deals in Healthcare & Biotech
Exited prioritisedMore from Normec Group
Original Source
View the original press release or news article describing this transaction in full.
Read Original PostAI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in